InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Mendel Scott, Directeur. Insider active across 4 companies, notably Akoya Biosciences, Inc.. Aggregated, 10 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €191k. History available since 19 November 2021. The latest transaction was disclosed on 1 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Mendel Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
8,073 股Common StockSEC:0001515051-26-000004:0
4,310 股0Common StockSEC:0001515051-26-000002:0
23,372 股0Common StockSEC:0001515051-26-000001:0
2,084 股@ US$5.54100.0% 占其流量Common StockSEC:0001515051-25-000003:0
4,189 股Common StockSEC:0001562180-25-005379:0
28,500 股Common StockSEC:0001062993-25-012732:0
20,000 股@ US$5.0032.1% 占其流量Common StockSEC:0001104659-23-070483:0
标准退出：2023年9月10日 (T+90)
141,843 股0Class A Common StockSEC:0001140361-23-025054:0
8,500 股@ US$13.1651.4% 占其流量Common StockSEC:0001104659-21-141727:0
标准退出：2022年2月17日 (T+90)
298 股Common StockSEC:0001487371-16-000193:0
10 条申报中的 10 条
About Mendel Scott
Mendel Scott is Director and has 10 filings in total. In the 10 recent filings we hold, the buy volume is EUR 191306, the sell volume is EUR 0, and the period runs from 2016-01-25 to 2026-07-09. The main filings concern Akoya Biosciences, Inc. and Quanterix Corp, with transactions of the Attribution type.
